Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CPI-1612 is a potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor that acts on EP300 HAT (IC50: 8.1 nM). CPI-1612 exhibits anticancer effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | 6-8 weeks | $ 996.00 | |
25 mg | 6-8 weeks | $ 2,110.00 |
Description | CPI-1612 is a potent, orally active EP300/CBP histone acetyltransferase (HAT) inhibitor that acts on EP300 HAT (IC50: 8.1 nM). CPI-1612 exhibits anticancer effects. |
Molecular Weight | 450.53 |
Formula | C27H26N6O |
CAS No. | 2374971-81-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CPI-1612 2374971-81-8 inhibitor inhibit